Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

High-sensitivity troponin I for cardiovascular risk stratification in the general asymptomatic population: Perspectives from Asia-Pacific.

Lam CSP, Castillo R, Ho DT, Kasliwal RR, Khurana R, Naik S, Omland T, Parsonage WA, Phrommintikul A, Tobing D, Yiu KKH.

Int J Cardiol. 2019 Feb 1. pii: S0167-5273(18)36403-9. doi: 10.1016/j.ijcard.2019.01.107. [Epub ahead of print]

PMID:
30745254
2.

Circulating Secretoneurin Concentrations After Cardiac Surgery: Data From the FINNish Acute Kidney Injury Heart Study.

Brynildsen J, Petäjä L, Myhre PL, Lyngbakken MN, Nygård S, Stridsberg M, Christensen G, Ottesen AH, Pettilä V, Omland T, Røsjø H.

Crit Care Med. 2019 Feb 5. doi: 10.1097/CCM.0000000000003670. [Epub ahead of print]

PMID:
30730440
3.

Can Circulating B-Type Natriuretic Peptide Concentrations Guide Treatment of Obstructive Left Main Coronary Artery Disease?

Omland T.

Circulation. 2018 Jul 31;138(5):479-482. doi: 10.1161/CIRCULATIONAHA.118.035272. No abstract available.

PMID:
30571535
4.

Novel biomarkers of cardiovascular disease: Applications in clinical practice.

Lyngbakken MN, Myhre PL, Røsjø H, Omland T.

Crit Rev Clin Lab Sci. 2019 Jan;56(1):33-60. doi: 10.1080/10408363.2018.1525335. Epub 2018 Nov 20.

PMID:
30457415
5.

Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB).

Saenger AK, Jaffe AS, Body R, Collinson PO, Kavsak PA, Lam CSP, Lefèvre G, Omland T, Ordóñez-Llanos J, Pulkki K, Apple FS.

Clin Chem Lab Med. 2018 Oct 6. pii: /j/cclm.ahead-of-print/cclm-2018-0905/cclm-2018-0905.xml. doi: 10.1515/cclm-2018-0905. [Epub ahead of print]

PMID:
30291783
6.

The authors reply.

Røsjø H, Caironi P, Meessen J, Latini R, Omland T; ALBIOS Biomarkers Study Investigators.

Crit Care Med. 2018 Sep;46(9):e959-e961. doi: 10.1097/CCM.0000000000003248. No abstract available.

PMID:
30113381
7.

Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study.

Berge T, Lyngbakken MN, Ihle-Hansen H, Brynildsen J, Pervez MO, Aagaard EN, Vigen T, Kvisvik B, Christophersen IE, Steine K, Omland T, Smith P, Røsjø H, Tveit A.

BMJ Open. 2018 Aug 1;8(7):e021704. doi: 10.1136/bmjopen-2018-021704.

8.

Diagnostic and prognostic properties of procalcitonin in patients with acute dyspnea: Data from the ACE 2 Study.

Berge K, Lyngbakken MN, Einvik G, Winther JA, Brynildsen J, Røysland R, Strand H, Christensen G, Høiseth AD, Omland T, Røsjø H.

Clin Biochem. 2018 Sep;59:62-68. doi: 10.1016/j.clinbiochem.2018.07.006. Epub 2018 Jul 17.

PMID:
30028971
9.

Cardiac Troponin T Concentrations, Reversible Myocardial Ischemia, and Indices of Left Ventricular Remodeling in Patients with Suspected Stable Angina Pectoris: a DOPPLER-CIP Substudy.

Myhre PL, Omland T, Sarvari SI, Ukkonen H, Rademakers F, Engvall JE, Hagve TA, Nagel E, Sicari R, Zamorano JL, Monaghan M, D'hooge J, Edvardsen T, Røsjø H; DOPPLER-CIP Study Group.

Clin Chem. 2018 Sep;64(9):1370-1379. doi: 10.1373/clinchem.2018.288894. Epub 2018 Jun 29.

PMID:
29959147
10.

Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.

Pervez MO, Winther JA, Brynildsen J, Strand H, Christensen G, Høiseth AD, Myhre PL, Røysland R, Lyngbakken MN, Omland T, Røsjø H.

Biomarkers. 2018 Nov;23(7):654-663. doi: 10.1080/1354750X.2018.1474258. Epub 2018 Sep 12.

PMID:
29733687
11.

The association between circulating adiponectin levels, lung function and adiposity in subjects from the general population; data from the Akershus Sleep Apnea Project.

Caspersen NF, Røsjø H, Flyvbjerg A, Bjerre M, Randby A, Hrubos-Strøm H, Omland T, Einvik G.

BMC Pulm Med. 2018 Apr 2;18(1):54. doi: 10.1186/s12890-018-0618-4.

12.

Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).

Sigurdardottir FD, Lyngbakken MN, Holmen OL, Dalen H, Hveem K, Røsjø H, Omland T.

Am J Cardiol. 2018 Apr 15;121(8):949-955. doi: 10.1016/j.amjcard.2018.01.004. Epub 2018 Feb 2.

PMID:
29496193
13.

Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.

Røsjø H, Masson S, Caironi P, Stridsberg M, Magnoli M, Christensen G, Moise G, Urbano MC, Gattinoni L, Pesenti A, Latini R, Omland T; ALBIOS Biomarkers Study Investigators.

Crit Care Med. 2018 May;46(5):e404-e410. doi: 10.1097/CCM.0000000000003050.

PMID:
29481425
14.

The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients.

Brynildsen J, Petäjä L, Pettilä V, Nygård S, Vaara ST, Linko R, Okkonen M, Hagve TA, Soininen L, Suojaranta-Ylinen R, Lyngbakken MN, Omland T, Røsjø H.

Clin Biochem. 2018 Mar;53:65-71. doi: 10.1016/j.clinbiochem.2018.01.012. Epub 2018 Jan 31.

PMID:
29371002
15.

The cardiac troponin response following physical exercise in relation to biomarker criteria for acute myocardial infarction; the North Sea Race Endurance Exercise Study (NEEDED) 2013.

Skadberg Ø, Kleiven Ø, Ørn S, Bjørkavoll-Bergseth MF, Melberg TH, Omland T, Aakre KM.

Clin Chim Acta. 2018 Apr;479:155-159. doi: 10.1016/j.cca.2018.01.033. Epub 2018 Feb 2.

PMID:
29366834
16.

Cardiac Troponin T Increase in Patients with Acute Ischemic Stroke with and without Cancer.

Faiz KW, Einvik G, Brekke PH, Omland T.

Clin Chem. 2018 Feb;64(2):404-406. doi: 10.1373/clinchem.2017.280016. Epub 2017 Nov 22. No abstract available.

17.

Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.

Gulati G, Heck SL, Røsjø H, Ree AH, Hoffmann P, Hagve TA, Norseth J, Gravdehaug B, Steine K, Geisler J, Omland T.

J Am Heart Assoc. 2017 Nov 8;6(11). pii: e006513. doi: 10.1161/JAHA.117.006513.

18.

Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial.

Heck SL, Gulati G, Hoffmann P, von Knobelsdorff-Brenkenhoff F, Storås TH, Ree AH, Gravdehaug B, Røsjø H, Steine K, Geisler J, Schulz-Menger J, Omland T.

Eur Heart J Cardiovasc Imaging. 2018 May 1;19(5):544-552. doi: 10.1093/ehjci/jex159.

PMID:
29106497
19.

Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.

Winther JA, Brynildsen J, Høiseth AD, Strand H, Følling I, Christensen G, Nygård S, Røsjø H, Omland T.

Respir Res. 2017 Nov 3;18(1):184. doi: 10.1186/s12931-017-0665-z.

20.

Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.

Lyngbakken MN, Pervez MO, Brynildsen J, Pedersen MH, Sølvernes J, Christensen G, Høiseth AD, Omland T, Røsjø H.

Clin Biochem. 2018 Feb;52:41-47. doi: 10.1016/j.clinbiochem.2017.10.015. Epub 2017 Oct 24.

PMID:
29074091
21.

Early diagnosis of acute coronary syndrome.

Katus H, Ziegler A, Ekinci O, Giannitsis E, Stough WG, Achenbach S, Blankenberg S, Brueckmann M, Collinson P, Comaniciu D, Crea F, Dinh W, Ducrocq G, Flachskampf FA, Fox KAA, Friedrich MG, Hebert KA, Himmelmann A, Hlatky M, Lautsch D, Lindahl B, Lindholm D, Mills NL, Minotti G, Möckel M, Omland T, Semjonow V.

Eur Heart J. 2017 Nov 1;38(41):3049-3055. doi: 10.1093/eurheartj/ehx492.

PMID:
29029109
22.

Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study.

Harrington JL, Ayers C, Berry JD, Omland T, Pandey A, Seliger SL, Ballantyne CM, Kulinski J, deFilippi CR, de Lemos JA.

Circulation. 2017 Oct 10;136(15):1451-1453. doi: 10.1161/CIRCULATIONAHA.117.029493. No abstract available.

23.

Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure.

Ottesen AH, Christensen G, Omland T, Røsjø H.

Curr Heart Fail Rep. 2017 Dec;14(6):478-488. doi: 10.1007/s11897-017-0360-x. Review.

PMID:
28975588
24.

Biomarker-Based Risk Models to Risk Stratify Patients With Stable Coronary Heart Disease.

Omland T, Kullo IJ.

J Am Coll Cardiol. 2017 Aug 15;70(7):827-829. doi: 10.1016/j.jacc.2017.06.051. No abstract available.

25.

Prognostic Value of Left Ventricular Deformation Parameters in Patients with Severe Aortic Stenosis: A Pilot Study of the Usefulness of Strain Echocardiography.

Klaeboe LG, Haland TF, Leren IS, Ter Bekke RMA, Brekke PH, Røsjø H, Omland T, Gullestad L, Aakhus S, Haugaa KH, Edvardsen T.

J Am Soc Echocardiogr. 2017 Aug;30(8):727-735.e1. doi: 10.1016/j.echo.2017.04.009. Epub 2017 Jun 7.

26.

Premature Ventricular Complex is More Prevalent During Acute Exacerbated than Stable States of Chronic Obstructive Pulmonary Disease, and Is Related to Cardiac Troponin T.

Einvik G, Bhatnagar R, Holmedahl NH, Neukamm A, Omland T, Søyseth V.

COPD. 2017 Jun;14(3):318-323. doi: 10.1080/15412555.2017.1298085. Epub 2017 Apr 7.

PMID:
28388306
27.

Glycosylated Chromogranin A in Heart Failure: Implications for Processing and Cardiomyocyte Calcium Homeostasis.

Ottesen AH, Carlson CR, Louch WE, Dahl MB, Sandbu RA, Johansen RF, Jarstadmarken H, Bjørås M, Høiseth AD, Brynildsen J, Sjaastad I, Stridsberg M, Omland T, Christensen G, Røsjø H.

Circ Heart Fail. 2017 Feb;10(2). pii: e003675. doi: 10.1161/CIRCHEARTFAILURE.116.003675.

PMID:
28209766
28.

Sex-Based Differences in Cardiometabolic Biomarkers.

Lew J, Sanghavi M, Ayers CR, McGuire DK, Omland T, Atzler D, Gore MO, Neeland I, Berry JD, Khera A, Rohatgi A, de Lemos JA.

Circulation. 2017 Feb 7;135(6):544-555. doi: 10.1161/CIRCULATIONAHA.116.023005.

29.

Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.

Pervez MO, Lyngbakken MN, Myhre PL, Brynildsen J, Langsjøen EC, Høiseth AD, Christensen G, Omland T, Røsjø H.

Clin Biochem. 2017 May;50(7-8):394-400. doi: 10.1016/j.clinbiochem.2016.12.010. Epub 2017 Jan 5.

PMID:
28065681
30.

Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study.

Myhre PL, Stridsberg M, Linko R, Okkonen M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H; FINNALI Study Group.

Biomarkers. 2017 Dec;22(8):775-781. doi: 10.1080/1354750X.2016.1269200. Epub 2017 Jan 3.

PMID:
28049363
31.

The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients.

Neukamm A, Einvik G, Didrik Høiseth A, Søyseth V, Henrik Holmedahl N, Kononova N, Omland T.

BMC Pulm Med. 2016 Nov 25;16(1):164.

32.

Biomarkers of cardiovascular injury and stress are associated with increased frequency of ventricular ectopy: a population-based study.

Skranes JB, Einvik G, Namtvedt SK, Randby A, Hrubos-Strøm H, Brynildsen J, Hagve TA, Somers VK, Røsjø H, Omland T.

BMC Cardiovasc Disord. 2016 Nov 22;16(1):233.

33.

Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study).

Lyngbakken MN, Skranes JB, de Lemos JA, Nygård S, Dalen H, Hveem K, Røsjø H, Omland T.

Circulation. 2016 Dec 13;134(24):1962-1972. Epub 2016 Nov 4.

PMID:
27815376
34.

State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease.

Omland T, White HD.

Clin Chem. 2017 Jan;63(1):165-176. doi: 10.1373/clinchem.2016.255190. Epub 2016 Nov 4. Review.

35.

Relation of Erectile Dysfunction to Subclinical Myocardial Injury.

Omland T, Randby A, Hrubos-Strøm H, Røsjø H, Einvik G.

Am J Cardiol. 2016 Dec 15;118(12):1821-1825. doi: 10.1016/j.amjcard.2016.08.070. Epub 2016 Sep 13.

PMID:
27780552
36.

The effect of surgical and non-surgical weight loss on N-terminal pro-B-type natriuretic peptide and its relation to obstructive sleep apnea and pulmonary function.

Gabrielsen AM, Omland T, Brokner M, Fredheim JM, Jordan J, Lehmann S, Lund MB, Hjelmesæth J, Hofsø D.

BMC Res Notes. 2016 Sep 13;9(1):440. doi: 10.1186/s13104-016-2241-x.

37.

Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study.

Myhre PL, Ottesen AH, Okkonen M, Linko R, Stridsberg M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H; FINNALI Laboratory Study Group.

Clin Chem. 2016 Oct;62(10):1380-9. doi: 10.1373/clinchem.2016.258764. Epub 2016 Aug 18.

38.

Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study.

Winther JA, Brynildsen J, Høiseth AD, Følling I, Brekke PH, Christensen G, Hagve TA, Verbalis JG, Omland T, Røsjø H.

PLoS One. 2016 Aug 16;11(8):e0161232. doi: 10.1371/journal.pone.0161232. eCollection 2016.

39.

Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study.

Røysland R, Pervez MO, Pedersen MH, Brynildsen J, Høiseth AD, Hagve TA, Røsjø H, Omland T.

PLoS One. 2016 Jul 27;11(7):e0160182. doi: 10.1371/journal.pone.0160182. eCollection 2016.

40.

Gender, High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trøndelag Health Study).

Lyngbakken MN, Røsjø H, Holmen OL, Nygård S, Dalen H, Hveem K, Omland T.

Am J Cardiol. 2016 Sep 15;118(6):816-821. doi: 10.1016/j.amjcard.2016.06.043. Epub 2016 Jun 28.

PMID:
27453509
41.

Prognostic Value of Secretoneurin in Critically Ill Patients With Infections.

Røsjø H, Stridsberg M, Ottesen AH, Nygård S, Christensen G, Pettilä V, Linko R, Karlsson S, Varpula T, Ruokonen E, Omland T; FINNSEPSIS and FINNALI Study Groups.

Crit Care Med. 2016 Oct;44(10):1882-90. doi: 10.1097/CCM.0000000000001832.

42.

Circulating microRNAs predict future fatal myocardial infarction in healthy individuals - The HUNT study.

Bye A, Røsjø H, Nauman J, Silva GJ, Follestad T, Omland T, Wisløff U.

J Mol Cell Cardiol. 2016 Aug;97:162-8. doi: 10.1016/j.yjmcc.2016.05.009. Epub 2016 May 15.

PMID:
27192016
43.

NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study.

Myhre PL, Tiainen M, Pettilä V, Vaahersalo J, Hagve TA, Kurola J, Varpula T, Omland T, Røsjø H; FINNRESUSCI Laboratory Study Group.

Resuscitation. 2016 Jul;104:12-8. doi: 10.1016/j.resuscitation.2016.04.007. Epub 2016 Apr 22.

PMID:
27109503
44.

Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery.

Petäjä L, Røsjø H, Mildh L, Suojaranta-Ylinen R, Kaukonen KM, Jokinen JJ, Salmenperä M, Hagve TA, Omland T, Pettilä V.

Interact Cardiovasc Thorac Surg. 2016 Jul;23(1):133-41. doi: 10.1093/icvts/ivw060. Epub 2016 Mar 16.

45.

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.

Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T.

Eur Heart J. 2016 Jun 1;37(21):1671-80. doi: 10.1093/eurheartj/ehw022. Epub 2016 Feb 21.

46.

The influence of heart failure co-morbidity on high-sensitivity troponin T levels in COPD exacerbation in a prospective cohort study: data from the Akershus cardiac examination (ACE) 2 study.

Høiseth AD, Brynildsen J, Hagve TA, Christensen G, Søyseth V, Omland T, Røsjø H.

Biomarkers. 2016;21(2):173-9. doi: 10.3109/1354750X.2015.1126645. Epub 2016 Jan 12. Erratum in: Biomarkers. 2016;21(2):i. Torbjørn, Omland [corrected to Omland, Torbjørn].

PMID:
26754170
47.

Effect of weight loss on subclinical myocardial injury: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.

Lyngbakken MN, Omland T, Nordstrand N, Norseth J, Hjelmesæth J, Hofsø D.

Eur J Prev Cardiol. 2016 May;23(8):874-80. doi: 10.1177/2047487315618796. Epub 2015 Dec 9.

PMID:
26656071
48.

B-Type Natriuretic Peptide as a Therapeutic Strategy: Opportunities and Pitfalls.

Røsjø H, Omland T.

Cardiology. 2016;133(2):119-21. doi: 10.1159/000441138. Epub 2015 Nov 3. No abstract available.

PMID:
26523893
49.

[Diagnostic accuracy for heart failure – data from the Akershus Cardiac Examination 2 Study].

Brynildsen J, Høiseth AD, Nygård S, Hagve TA, Christensen G, Omland T, Røsjø H.

Tidsskr Nor Laegeforen. 2015 Oct 20;135(19):1738-44. doi: 10.4045/tidsskr.14.1174. eCollection 2015 Oct 20. Norwegian.

50.

Heart and Brain Interactions--the Akershus Cardiac Examination (ACE) 1950 Study Design.

Berge T, Vigen T, Pervez MO, Ihle-Hansen H, Lyngbakken MN, Omland T, Smith P, Steine K, Røsjø H, Tveit A; ACE 1950 Study Group.

Scand Cardiovasc J. 2015;49(6):308-15. doi: 10.3109/14017431.2015.1086813. Epub 2015 Sep 12.

PMID:
26364744

Supplemental Content

Loading ...
Support Center